Header Logo

Diana Caragacianu

Concepts (144)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mammaplasty
3
2021
43
1.370
Why?
Breast Neoplasms
9
2021
1118
1.190
Why?
Mastectomy, Segmental
4
2021
45
0.880
Why?
Mastectomy
4
2020
52
0.870
Why?
Surgical Flaps
2
2021
110
0.700
Why?
Pregnancy Complications, Neoplastic
1
2016
11
0.530
Why?
Thyroidectomy
3
2017
31
0.480
Why?
Recurrent Laryngeal Nerve
1
2013
4
0.430
Why?
Vocal Cord Paralysis
1
2013
10
0.430
Why?
Glottis
1
2013
13
0.430
Why?
Monitoring, Intraoperative
1
2013
42
0.430
Why?
Thyroid Neoplasms
4
2017
71
0.430
Why?
Recovery of Function
1
2013
270
0.380
Why?
Postoperative Complications
3
2019
1204
0.250
Why?
Lymph Nodes
2
2017
214
0.240
Why?
Organ Size
1
2021
164
0.180
Why?
Anatomic Variation
1
2020
6
0.180
Why?
Thoracic Wall
1
2020
17
0.170
Why?
Nipples
1
2019
14
0.160
Why?
Organ Sparing Treatments
1
2019
15
0.160
Why?
Carcinoma, Ductal, Breast
1
2019
45
0.160
Why?
Neoadjuvant Therapy
1
2019
71
0.150
Why?
Prognosis
4
2019
1597
0.150
Why?
Neck Dissection
2
2017
18
0.150
Why?
Female
13
2021
30719
0.150
Why?
Middle Aged
10
2021
16310
0.150
Why?
Lymphatic Metastasis
3
2017
74
0.140
Why?
Follow-Up Studies
4
2019
2338
0.140
Why?
Intraoperative Care
2
2016
36
0.140
Why?
Humans
18
2021
59366
0.130
Why?
Breast Implants
1
2016
13
0.130
Why?
Neoplasm, Residual
1
2016
38
0.130
Why?
Carcinoma
1
2017
116
0.130
Why?
Gestational Age
1
2016
178
0.120
Why?
Retrospective Studies
6
2019
6069
0.120
Why?
Muscle, Skeletal
1
2020
674
0.120
Why?
Adult
9
2019
15679
0.120
Why?
Carcinoma, Papillary
2
2017
35
0.120
Why?
Breast Neoplasms, Male
1
2014
14
0.120
Why?
Thyroid Nodule
1
2014
14
0.110
Why?
Surgery, Computer-Assisted
1
2014
56
0.110
Why?
Multimodal Imaging
1
2014
64
0.110
Why?
Thyroid Gland
1
2014
79
0.110
Why?
Vocal Cords
1
2013
6
0.110
Why?
Spectrometry, Mass, Electrospray Ionization
1
2014
93
0.110
Why?
Electromyography
1
2013
88
0.110
Why?
Operative Time
1
2013
76
0.100
Why?
Postoperative Period
1
2013
127
0.100
Why?
Breast Diseases
1
2013
39
0.100
Why?
Cell Transformation, Neoplastic
1
2014
193
0.100
Why?
Neoplasm Recurrence, Local
1
2015
300
0.100
Why?
Radiographic Image Enhancement
1
2013
97
0.100
Why?
Laryngoscopy
1
2013
61
0.100
Why?
Magnetic Resonance Imaging
3
2017
2052
0.100
Why?
Mammography
1
2013
269
0.090
Why?
Cohort Studies
1
2016
2375
0.090
Why?
Prospective Studies
2
2016
3067
0.080
Why?
Lymph Node Excision
1
2009
38
0.080
Why?
Pregnancy
1
2016
2213
0.080
Why?
Treatment Outcome
2
2016
5281
0.080
Why?
Young Adult
5
2017
4273
0.070
Why?
Intercellular Signaling Peptides and Proteins
1
2009
152
0.070
Why?
Neoplasm Staging
3
2015
448
0.070
Why?
Antigens, Neoplasm
1
2008
133
0.070
Why?
Neoplasms, Experimental
1
2008
75
0.070
Why?
Lymphocytes
1
2008
190
0.070
Why?
Neovascularization, Pathologic
1
2008
137
0.070
Why?
Repressor Proteins
1
2009
331
0.070
Why?
Supine Position
2
2017
31
0.070
Why?
Neoplasms
2
2014
1231
0.070
Why?
Combined Modality Therapy
2
2019
354
0.070
Why?
Epigenesis, Genetic
1
2008
357
0.060
Why?
Aged
6
2017
13405
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
402
0.060
Why?
Cell Proliferation
1
2008
941
0.050
Why?
Lung Neoplasms
1
2009
584
0.050
Why?
Incidental Findings
1
2020
41
0.040
Why?
Cell Line, Tumor
3
2009
1368
0.040
Why?
Prone Position
1
2017
27
0.030
Why?
Perioperative Care
1
2017
76
0.030
Why?
Patient Positioning
1
2016
44
0.030
Why?
Adolescent
2
2017
5835
0.030
Why?
Republic of Korea
1
2015
29
0.030
Why?
Neoplasm Grading
1
2015
79
0.030
Why?
Oleic Acid
1
2014
21
0.030
Why?
Demography
1
2015
169
0.030
Why?
Tumor Burden
1
2014
59
0.030
Why?
Biopsy, Fine-Needle
1
2014
61
0.030
Why?
Predictive Value of Tests
1
2017
1027
0.030
Why?
Neoplasm Invasiveness
1
2015
248
0.030
Why?
Probability
1
2014
167
0.030
Why?
Fatty Acids
1
2014
190
0.030
Why?
Disease Management
1
2015
220
0.030
Why?
Recurrence
1
2014
602
0.030
Why?
Efficiency, Organizational
1
2013
93
0.030
Why?
Feasibility Studies
1
2014
525
0.020
Why?
Lipids
1
2014
300
0.020
Why?
Aged, 80 and over
2
2013
5119
0.020
Why?
Diagnosis, Differential
1
2014
931
0.020
Why?
Pilot Projects
1
2014
914
0.020
Why?
Biomarkers, Tumor
1
2014
461
0.020
Why?
Thyroglobulin
1
2009
9
0.020
Why?
Male
3
2017
27742
0.020
Why?
Polycomb Repressive Complex 2
1
2009
16
0.020
Why?
Enhancer of Zeste Homolog 2 Protein
1
2009
15
0.020
Why?
Polycomb-Group Proteins
1
2009
21
0.020
Why?
Smoke
1
2009
23
0.020
Why?
Sirtuin 1
1
2009
25
0.020
Why?
Acetylation
1
2009
112
0.020
Why?
Sirtuins
1
2009
26
0.020
Why?
Wnt Proteins
1
2009
91
0.020
Why?
Mice, Nude
1
2009
258
0.020
Why?
Transplantation, Heterologous
1
2009
223
0.020
Why?
Down-Regulation
1
2009
305
0.020
Why?
Cysteine
1
2008
107
0.020
Why?
Thalidomide
1
2008
32
0.020
Why?
Cyclophosphamide
1
2008
75
0.020
Why?
Pyrroles
1
2008
45
0.020
Why?
Cloning, Molecular
1
2008
381
0.020
Why?
Fluorescent Antibody Technique
1
2008
217
0.020
Why?
Cross-Sectional Studies
1
2014
2380
0.020
Why?
Ultrasonography
1
2009
457
0.020
Why?
Indoles
1
2008
106
0.020
Why?
Models, Genetic
1
2008
255
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
178
0.020
Why?
DNA Methylation
1
2009
271
0.020
Why?
Receptors, Antigen, T-Cell
1
2008
281
0.020
Why?
Endothelial Cells
1
2008
173
0.020
Why?
Promoter Regions, Genetic
1
2009
650
0.020
Why?
Immunotherapy
1
2008
228
0.020
Why?
Gene Expression Profiling
1
2009
718
0.020
Why?
Mice
2
2009
10294
0.010
Why?
Peptides
1
2008
549
0.010
Why?
Cytokines
1
2008
915
0.010
Why?
Rats
1
2008
1910
0.010
Why?
T-Lymphocytes
1
2008
986
0.010
Why?
RNA, Small Interfering
1
2009
857
0.010
Why?
DNA-Binding Proteins
1
2009
1151
0.010
Why?
Genetic Vectors
1
2008
808
0.010
Why?
United States
1
2015
7426
0.010
Why?
Transcription Factors
1
2009
1471
0.010
Why?
Animals
2
2009
19649
0.010
Why?
Risk Factors
1
2009
4986
0.010
Why?
Signal Transduction
1
2009
2903
0.010
Why?
Caragacianu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (144)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_